Thiwáhe Gluwáš'akapi for Substance Abuse
Study Summary
This trial will test the effectiveness of an adapted Strengthening Families Program, called Thiwáhe Gluwáš'akapi, for delaying the onset of substance use and reducing suicide risk among young adolescents, as well as reducing substance abuse among adults.
- Substance Abuse
- Suicide
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Awards & Highlights
Trial Design
Find a site
Who is running the clinical trial?
Media Library
Frequently Asked Questions
Is this research project presently open for enrolment?
"Based on the information provided by clinicaltrials.gov, this trial is not presently recruiting participants and has been in a dormant state since April 12th 2022. However, there are currently 521 other trials actively searching for candidates at this time."
What outcomes is this research endeavor attempting to prove?
"This clinical trial, which is assessed over a Change from baseline to 36 months after intervention period, aims to reduce the initiation of cigarette smoking. Secondary outcomes include trajectories of change in Substance use attitudes [youth only], Parent warmth [adult reports] and Past week depression [youth only]. These targets are measured at regular 6-month intervals for three years."
To which population is this research initiative accessible?
"The criteria for a potential participant in this suicide prevention trial is between 10 to 85 years old. Furthermore, they must meet the following conditions: being aged 10-12 on the first day of participation and attending school at an eligible reservation; enrolling with an adult of legal age (18+) who has a significant parenting role in their life such as parent/grandparent or other household member."
Does this clinical trial extend its reach to senior citizens?
"The age range for suitable applicants to this medical trial is between 10 and 85 years old."